国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pyrococcus kodakaraensis Phosphoribosylamine--glycine ligase (purD) CSB-YP689303FHY
CSB-EP689303FHY
CSB-BP689303FHY
CSB-MP689303FHY
CSB-EP689303FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP689304FHY
CSB-EP689304FHY
CSB-BP689304FHY
CSB-MP689304FHY
CSB-EP689304FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Quinolinate synthase A (nadA) CSB-YP689305FHY
CSB-EP689305FHY
CSB-BP689305FHY
CSB-MP689305FHY
CSB-EP689305FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Uridylate kinase (pyrH) CSB-YP689306FHY
CSB-EP689306FHY
CSB-BP689306FHY
CSB-MP689306FHY
CSB-EP689306FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Nascent polypeptide-associated complex protein (nac) CSB-YP689307FHY
CSB-EP689307FHY
CSB-BP689307FHY
CSB-MP689307FHY
CSB-EP689307FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis UPF0212 protein TK1194 (TK1194) CSB-YP689308FHY
CSB-EP689308FHY
CSB-BP689308FHY
CSB-MP689308FHY
CSB-EP689308FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis UPF0107 protein TK1248 (TK1248) CSB-YP689309FHY
CSB-EP689309FHY
CSB-BP689309FHY
CSB-MP689309FHY
CSB-EP689309FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Intracellular protease 1 (pfpI) CSB-YP689310FHY
CSB-EP689310FHY
CSB-BP689310FHY
CSB-MP689310FHY
CSB-EP689310FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 50S ribosomal protein L7Ae (rpl7ae) CSB-YP689311FHY
CSB-EP689311FHY
CSB-BP689311FHY
CSB-MP689311FHY
CSB-EP689311FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis UPF0095 protein TK1410 (TK1410) CSB-YP689312FHY
CSB-EP689312FHY
CSB-BP689312FHY
CSB-MP689312FHY
CSB-EP689312FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Adenylate kinase (adk) CSB-YP689313FHY
CSB-EP689313FHY
CSB-BP689313FHY
CSB-MP689313FHY
CSB-EP689313FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Type 2 DNA topoisomerase 6 subunit B (top6B), partial CSB-YP689314FHY
CSB-EP689314FHY
CSB-BP689314FHY
CSB-MP689314FHY
CSB-EP689314FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Pantoate kinase (TK2141) CSB-YP689315FHY
CSB-EP689315FHY
CSB-BP689315FHY
CSB-MP689315FHY
CSB-EP689315FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis DNA double-strand break repair Rad50 ATPase (rad50), partial CSB-YP689316FHY
CSB-EP689316FHY
CSB-BP689316FHY
CSB-MP689316FHY
CSB-EP689316FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis tRNA-splicing endonuclease (endA) CSB-YP689317FHY
CSB-EP689317FHY
CSB-BP689317FHY
CSB-MP689317FHY
CSB-EP689317FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Putative L-asparaginase (TK2246) CSB-YP689318FHY
CSB-EP689318FHY
CSB-BP689318FHY
CSB-MP689318FHY
CSB-EP689318FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Ribosomal RNA small subunit methyltransferase Nep1 (nep1) CSB-YP689319FHY
CSB-EP689319FHY
CSB-BP689319FHY
CSB-MP689319FHY
CSB-EP689319FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus kodakarensis N-glycosylase/DNA lyase (TK0940) CSB-YP689320FHY
CSB-EP689320FHY
CSB-BP689320FHY
CSB-MP689320FHY
CSB-EP689320FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Alanine--tRNA ligase (alaS), partial CSB-YP689321FHY
CSB-EP689321FHY
CSB-BP689321FHY
CSB-MP689321FHY
CSB-EP689321FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis V-type ATP synthase subunit F (atpF) CSB-YP689322FHY
CSB-EP689322FHY
CSB-BP689322FHY
CSB-MP689322FHY
CSB-EP689322FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>